Repligen Corp
RGENHealthcare·Medical Instruments & Supplies·USA·Large·NASD·Nov 11 • 3:59 PM ET
172.62-1.36 (-0.78%)
2026-11-11 23:01 CET
Market cap
11,121.45 USD m
Revenue, TTM
805.61 USD m
Net income, TTM
-11.80 USD m
Free cash flow, TTM
105.26 USD m
EPS diluted, TTM
-0.21
P/E
-
Price
RGEN against its 20, 50 and 200-day averages2050200miss
13.2% under the 52-week high of 198.87 on 28 Sep 2026. 52-week low 100.99 on 14 May 2026. Last 15 sessions, 15.9% high to low
Volume 0.84× normal · the line is the 50-bar volume average
Profile
RGEN52-week range, 73% of the way up
100.99198.87
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
| Index | RUI |
|---|---|
| Employees | 2000 |
| IPO | Apr 29, 1986 |
| Beta | 1.12 |
| ATR, 14d | 8.77 |
| Rel volume | 0.84 |
| Short float | 11.68% |
| Insider own | 5.56% |
| Inst own | 110.56% |
Snapshot
6 groupsValuation
| Index | RUI |
|---|---|
| Market Cap | 11.03B |
| Enterprise Value | 10.86B |
| Income | -11.80M |
| Sales | 805.61M |
| Book/sh | 36.90 |
| Cash/sh | 13.53 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | 0.00% |
| Employees | 2000 |
| IPO | Apr 29, 1986 |
Ratios
| P/E | - |
|---|---|
| Forward P/E | 64.97 |
| PEG | 2.49 |
| P/S | 13.70 |
| P/B | 4.68 |
| P/C | 12.76 |
| P/FCF | 104.83 |
| EV/EBITDA | 65.04 |
| EV/Sales | 13.48 |
| Quick Ratio | 8.43 |
| Current Ratio | 9.88 |
| Debt/Eq | 0.33 |
| LT Debt/Eq | 0.32 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | -0.21 |
|---|---|
| EPS next Y | 2.66 |
| EPS next Q | 0.52 |
| EPS this Y | 21.28% |
| EPS next Y | 28.12% |
| EPS next 5Y | 26.05% |
| EPS past 3/5Y | -35.60% -4.91% |
| Sales past 3/5Y | -2.70% 15.05% |
| EPS Y/Y TTM | -811.00% |
| Sales Y/Y TTM | 13.80% |
| EPS Q/Q | -357.58% |
| Sales Q/Q | 10.86% |
| Earnings | Oct 27 BMO |
| EPS/Sales Surpr. | 14.52% 1.26% |
Ownership
| Insider Own | 5.56% |
|---|---|
| Insider Trans | -0.94% |
| Inst Own | 110.56% |
| Inst Trans | 3.85% |
| ROA | -0.40% |
| ROE | -0.57% |
| ROIC | -0.43% |
| Gross Margin | 48.89% |
| Oper. Margin | 8.63% |
| Profit Margin | -1.47% |
| SMA20 | -2.85% |
| SMA50 | -2.65% |
| SMA200 | 18.90% |
| Trades | - |
Technical
| Shs Outstand | 63.92M |
|---|---|
| Shs Float | 60.37M |
| Short Float | 11.68% |
| Short Ratio | 5.95 |
| Short Interest | 7.05M |
| 52W High | 198.87 -13.20% |
| 52W Low | 100.99 70.93% |
| Volatility | 4.99% 4.88% |
| ATR (14) | 8.77 |
| RSI (14) | 46.56 |
| Beta | 1.12 |
| Rel Volume | 0.84 |
| Avg Volume | 1.19M |
| Volume | 999,773 |
Performance
| Perf Week | -3.13% |
|---|---|
| Perf Month | -1.60% |
| Perf Quarter | 3.06% |
| Perf Half Y | 61.28% |
| Perf YTD | 5.35% |
| Perf Year | 12.50% |
| Perf 3Y | 16.98% |
| Perf 5Y | -35.35% |
| Perf 10Y | 434.59% |
| Recom | 1.61 |
| Target Price | 204.50 |
| Prev Close | 173.98 |
| Price | 172.62 |
| Change % | -0.78% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Sep 09, 2026 | Resumed | UUBS | Buy | $225 | +30.3% |
| Jul 07, 2026 | Upgrade | TThe Benchmark Company | Hold → Buy | $185 | +7.2% |
| Jun 02, 2026 | Resumed | WWolfe Research | Outperform | $145 | -16.0% |
| May 15, 2026 | Resumed | RRBC Capital Mkts | Outperform | $160 | -7.3% |
| Apr 17, 2026 | Initiated | RRothschild & Co Redburn | Buy | $160 | -7.3% |
| Oct 01, 2025 | Initiated | HHSBC Securities | Buy | $150 | -13.1% |
| Sep 22, 2025 | Upgrade | EEvercore ISI | In-line → Outperform | $155 | -10.2% |
| Jul 22, 2025 | Resumed | SStephens | Overweight | $160 | -7.3% |
| Jun 24, 2025 | Initiated | BBarclays | Overweight | $150 | -13.1% |
| Apr 29, 2025 | Upgrade | WWolfe Research | Peer Perform → Outperform | $160 | -7.3% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| AVTR | Avantor Inc | 10.66B |
| DHR | Danaher Corp | 165.55B |
| TMO | Thermo Fisher Scientific Inc | 265.92B |
| WST | West Pharmaceutical Services Inc | 28.76B |
| BIO | Bio-Rad Laboratories Inc | 10.39B |
| STVN | Stevanato Group Spa | 3.80B |
| TECH | Bio-Techne Corp | 11.44B |
| WAT | Waters Corp | 46.27B |
| A | Agilent Technologies Inc | 49.89B |
| MTD | Mettler-Toledo International Inc | 34.79B |
Insider trading
latest 14 of 35| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Loeillot Olivier | Chief Executive Officer | Oct 05 '26 | Option Exercise | 154.96 | 4,202 | 651,142 | 49,990 | Oct 06 04:18 PM |
| Loeillot Olivier | Chief Executive Officer | Oct 05 '26 | Sale | 187.29 | 5,535 | 1,036,654 | 45,788 | Oct 06 04:18 PM |
| Loeillot Olivier | Officer | Oct 05 '26 | Proposed Sale | 190.00 | 4,202 | 798,380 | Oct 05 04:10 PM | |
| Loeillot Olivier | Officer | Oct 05 '26 | Proposed Sale | 178.75 | 1,333 | 238,274 | Oct 05 01:14 PM | |
| Loeillot Olivier | Chief Executive Officer | Sep 24 '26 | Option Exercise | 155.11 | 12,946 | 2,008,020 | 56,773 | Sep 25 04:09 PM |
| Loeillot Olivier | Chief Executive Officer | Sep 24 '26 | Sale | 190.00 | 12,946 | 2,459,740 | 48,369 | Sep 25 04:09 PM |
| Loeillot Olivier | Officer | Sep 24 '26 | Proposed Sale | 190.00 | 12,946 | 2,459,740 | Sep 24 05:04 PM | |
| Loeillot Olivier | Chief Executive Officer | Sep 21 '26 | Option Exercise | 141.79 | 5,426 | 769,353 | 53,795 | Sep 22 04:07 PM |
| Loeillot Olivier | Chief Executive Officer | Sep 21 '26 | Sale | 180.00 | 5,426 | 976,680 | 48,369 | Sep 22 04:07 PM |
| Loeillot Olivier | Officer | Sep 21 '26 | Proposed Sale | 180.00 | 5,426 | 976,680 | Sep 21 03:03 PM | |
| Loeillot Olivier | Chief Executive Officer | Sep 04 '26 | Sale | 165.90 | 3,035 | 503,506 | 48,369 | Sep 08 04:13 PM |
| Loeillot Olivier | Officer | Sep 04 '26 | Proposed Sale | 165.90 | 3,035 | 503,506 | Sep 04 10:01 AM | |
| Loeillot Olivier | Chief Executive Officer | Aug 20 '26 | Option Exercise | 141.79 | 5,426 | 769,353 | 59,672 | Aug 21 04:06 PM |
| Loeillot Olivier | Chief Executive Officer | Aug 20 '26 | Sale | 180.00 | 5,426 | 976,680 | 54,246 | Aug 21 04:06 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IJH | iShares Core S&P Mid-Cap ETF | AUM: 124.48B |
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 687.42B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 79.59B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.34B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.47B |
| FBT | First Trust NYSE Arca Biotechnology Index Fund | AUM: 3.03B |
| MDY | State Street SPDR S&P MIDCAP 400 ETF Trust | AUM: 26.22B |
| IBB | iShares Biotechnology ETF | AUM: 11.36B |
| DFAS | U.S. Small Cap Portfolio-ETF Class Shares | AUM: 15.51B |
| SPMD | State Street SPDR Portfolio S&P 400TM Mid Cap ETF | AUM: 18.90B |
News
latest 14 of 200- Repligen Corporation to Present at Jefferies Global Healthcare Conference (GlobeNewswire)
- Repligen Announces $1 Billion Private Convertible Senior Notes Transaction (GlobeNewswire) -6.20%
- Repligen Beats And Raises Again, But BioLife Does The Heavy Lifting On Guidance While Filtration Weakens (Earnings Whispers)
- Repligen: Q3 Earnings Snapshot (Associated Press)
- Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance (GlobeNewswire)
- Repligen to Report Third Quarter 2026 Financial Results (GlobeNewswire)
- Repligen Completes Acquisition of BioLife Solutions (GlobeNewswire) -7.73%
- Freshworks Set to Join S&P SmallCap 600 (PR Newswire)
- Freshworks stock climbs on S&P SmallCap 600 inclusion (Investing.com)
- Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs? (Stocktwits)
- Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference (GlobeNewswire)
- These Two Biotech Stocks Recorded Fresh Milestones Today Whats Driving Todays Gains? (Stocktwits) +6.15%
- Repligen Corp (RGEN) Q2 2026 Earnings Call Highlights: Strong Growth and Raised Guidance Amidst ... (GuruFocus.com) +10.90%
- Repligen Reports Q2 Revenue Growth and Raises Full-Year 2026 Guidance (InvestorsHub)
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-10-27 | 0.530 | 0.463 | -0.680 | 209.31 | 206.7 | 18 |
| 2026Q2 | 2026-07-28 | 0.540 | 0.447 | 0.088 | 204.13 | 201.59 | 18 |
| 2026Q1 | 2026-05-05 | 0.480 | 0.384 | 0.147 | 194.26 | 192.05 | 17 |
| 2025Q4 | 2026-02-24 | 0.490 | 0.440 | 0.235 | 197.91 | 192.89 | 19 |
| 2025Q3 | 2025-10-28 | 0.460 | 0.422 | 0.264 | 188.81 | 182.17 | 19 |
| 2025Q2 | 2025-07-29 | 0.370 | 0.388 | 0.263 | 182.37 | 175.18 | 19 |
| 2025Q1 | 2025-04-29 | 0.390 | 0.346 | 0.103 | 169.17 | 163.69 | 18 |
| 2024Q4 | 2025-02-20 | 0.440 | 0.410 | -0.604 | 167.55 | 167.65 | 17 |
| 2024Q3 | 2024-11-12 | 0.430 | 0.335 | -0.012 | 150.76 | 153.02 | 12 |
| 2024Q2 | 2024-07-30 | 0.330 | 0.326 | 0.101 | 154.07 | 154.11 | 13 |
| 2024Q1 | 2024-05-01 | 0.280 | 0.301 | 0.058 | 151.35 | 150.06 | 12 |
| 2023Q4 | 2024-02-21 | 0.330 | 0.326 | -0.295 | 142.07 | 155.38 | 11 |
| 2023Q3 | 2023-10-31 | 0.230 | 0.165 | 0.297 | 141.19 | 140.69 | 13 |
| 2023Q2 | 2023-08-02 | 0.530 | 0.475 | 0.348 | 159.2 | 165.93 | 13 |
| 2023Q1 | 2023-05-02 | 0.640 | 0.588 | 0.269 | 182.66 | 181.42 | 12 |
| 2022Q4 | 2023-02-22 | 0.680 | 0.577 | 0.853 | 186.76 | 184.55 | 11 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2019FY | 1.070 | 1.031 | 0.435 | 270.25 | 269.14 |
| 2020FY | 1.650 | 1.436 | 1.112 | 366.26 | 351.59 |
| 2021FY | 3.060 | 2.900 | 2.240 | 670.53 | 664.36 |
| 2022FY | 3.280 | 3.183 | 3.237 | 801.54 | 799.57 |
| 2023FY | 1.750 | 1.729 | 0.631 | 638.76 | 638.45 |
| 2024FY | 1.580 | 1.538 | -0.456 | 634.44 | 634.15 |
| 2025FY | 1.710 | 1.664 | 0.860 | 738.26 | 733.09 |
| 2026FY | - | 2.074 | - | - | 848.87 |
| 2027FY | - | 2.657 | - | - | 1,069 |
| 2028FY | - | 3.425 | - | - | 1,233 |
| 2029FY | - | 4.436 | - | - | 1,401 |
| 2030FY | - | 5.585 | - | - | 1,592 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-05 | 16 | 13 | 3 | 241.03 | 239.8 | 245.7 |
| 2026Q4 | S | 2026-10-27 | 17 | 13 | 3 | 239.79 | 220 | 245.7 |
| 2026Q4 | S | 2026-10-26 | 17 | 2 | 0 | 225.48 | 215 | 251 |
| 2026Q4 | S | 2026-10-16 | 17 | 2 | 0 | 225.48 | 215 | 251 |
| 2026Q4 | S | 2026-10-15 | 17 | 1 | 0 | 223.83 | 215 | 251 |
| 2026Q4 | S | 2026-10-13 | 17 | 1 | 0 | 223.83 | 215 | 251 |
| 2026Q4 | S | 2026-10-11 | 17 | 1 | 0 | 223.83 | 215 | 251 |
| 2026Q4 | S | 2026-10-09 | 17 | 4 | 2 | 223.83 | 215 | 251 |
| 2026Q4 | S | 2026-09-30 | 17 | 3 | 2 | 222.08 | 215 | 251 |
| 2026Q4 | S | 2026-09-28 | 17 | 3 | 2 | 222.09 | 215 | 251 |
| 2026Q4 | S | 2026-09-08 | 18 | 3 | 2 | 222.17 | 215 | 251 |
| 2026Q4 | S | 2026-07-29 | 17 | 3 | 2 | 222.33 | 215 | 251 |
| 2026Q4 | S | 2026-07-28 | 16 | 3 | 2 | 222.25 | 215 | 251 |
| 2026Q4 | S | 2026-07-27 | 15 | 0 | 1 | 220.32 | 210 | 228.4 |
Estimate history
| EPS, annual | 0.72 | 0.365 | 0.435 | 1.112 | 2.24 | 3.237 | 0.631 | -0.456 | 0.864 | -0.2095 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | -0.012 | -0.604 | 0.103 | 0.263 | 0.264 | 0.235 | 0.147 | 0.088 | -0.68 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 141.236 | 194.032 | 270.245 | 366.26 | 670.534 | 801.536 | 632.362 | 634.439 | 738.256 | 805.61 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 154.871 | 167.547 | 169.172 | 182.366 | 188.805 | 197.913 | 194.255 | 204.128 | 209.314 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 43.587 | 43.917 | 52.078 | 54.761 | 55.321 | 55.558 | 55.766 | 56.092 | 56.325 | 56.693 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 56.027 | 56.092 | 56.179 | 56.253 | 56.283 | 56.325 | 56.399 | 56.427 | 56.693 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 805.61 | 738.26 | 634.44 | 632.36 | 801.54 | 670.53 | 366.26 | 270.25 | 194.03 |
| Cost of Goods Sold Incl. D&A | 411.76 | 387.62 | 350.44 | 355.09 | 372.92 | 297.59 | 171.91 | 132.02 | 97.11 |
| Gross Profit | 393.85 | 350.63 | 284.00 | 277.27 | 428.62 | 372.95 | 194.35 | 138.22 | 96.92 |
| Selling, General and Administrative Excl. Other | 324.34 | 289.34 | 261.35 | 227.94 | 232.68 | 179.70 | 113.07 | 98.14 | 68.03 |
| Research and Development | 55.49 | 51.31 | 42.75 | 42.61 | 43.94 | 32.88 | 19.66 | 19.45 | 15.82 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 69.51 | 61.30 | 22.65 | 49.33 | 195.94 | 193.25 | 81.29 | 40.08 | 28.89 |
| Interest Expense | 24.13 | 23.17 | 22.57 | 10.58 | 2.98 | 12.71 | 12.13 | 9.29 | 6.71 |
| Unusual Expense | 51.27 | 6.13 | 57.24 | 14.31 | -28.73 | 26.01 | 11.46 | 9.65 | 2.90 |
| Net Income Before Taxes | 8.23 | 62.38 | -27.04 | 56.71 | 219.14 | 153.54 | 59.22 | 26.15 | 21.44 |
| Income Taxes | 20.03 | 13.49 | -1.52 | 21.11 | 33.18 | 25.25 | -0.71 | 4.74 | 4.82 |
| Consolidated Net Income | -11.80 | 48.89 | -25.51 | 35.60 | 185.96 | 128.29 | 59.93 | 21.41 | 16.62 |
| Net Income From Continuing Operations | -11.80 | 48.89 | -25.51 | 35.60 | 185.96 | 128.29 | 59.93 | 21.41 | 16.62 |
| Net Income | -11.80 | 48.89 | -25.51 | 35.60 | 185.96 | 128.29 | 59.93 | 21.41 | 16.62 |
| EPS (Recurring) | 0.43 | 0.94 | 0.26 | 0.81 | 2.89 | 2.56 | 1.26 | 0.57 | 0.41 |
| EPS (Basic, Before Extraordinaries) | -0.21 | 0.87 | -0.46 | 0.64 | 3.35 | 2.33 | 1.14 | 0.44 | 0.38 |
| EPS (Diluted) | -0.21 | 0.86 | -0.46 | 0.63 | 3.24 | 2.24 | 1.11 | 0.44 | 0.37 |
| EBITDA | 167.00 | 158.25 | 109.21 | 135.45 | 252.95 | 231.69 | 108.36 | 60.95 | 44.67 |
| Non-Operating Income (Expense) | 14.12 | 30.39 | 30.13 | 32.26 | -2.55 | -0.98 | 1.53 | 5.01 | 2.16 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 26.60 | 25.76 | 37.98 | 20.20 | 21.58 | 20.07 | 12.42 | 9.38 | 8.05 |
| Price To Earnings Ratio | - | - | - | 88.54 | 58.65 | 118.01 | 172.25 | 210.66 | 145.77 |
| Price To Sales Ratio | 13.50 | 12.55 | 12.69 | 16.03 | 12.14 | 22.62 | 28.20 | 16.84 | 12.36 |
| Gross Margin | 48.89 | 47.50 | 44.76 | 43.85 | 53.47 | 55.62 | 53.06 | 51.15 | 49.95 |
| Operating Margin | 8.63 | 8.30 | 3.57 | 7.80 | 24.45 | 28.82 | 22.19 | 14.83 | 14.89 |
| Net Margin | -1.47 | 6.62 | -4.02 | 5.63 | 23.20 | 19.13 | 16.36 | 7.92 | 8.56 |
| Shares Outstanding | 56.69 | 56.33 | 56.09 | 55.77 | 55.56 | 55.32 | 54.76 | 52.08 | 43.92 |
| Market Capitalization | 11,121.45 | 11,121.45 | 8,064.48 | 10,038.59 | 9,400.84 | 14,642.61 | 10,370.88 | 4,815.45 | 2,313.12 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 209.31 | 204.13 | 194.25 | 197.91 | 188.81 | 182.37 | 169.17 | 167.55 |
| Cost of Goods Sold Incl. D&A | 107.93 | 103.59 | 95.77 | 104.47 | 98.19 | 99.67 | 86.90 | 91.81 |
| Gross Profit | 101.39 | 100.54 | 98.48 | 93.44 | 90.61 | 82.69 | 82.27 | 75.74 |
| Selling, General and Administrative Excl. Other | 88.03 | 80.94 | 80.49 | 74.89 | 75.84 | 74.58 | 72.82 | 61.36 |
| Research and Development | 14.44 | 14.42 | 14.46 | 12.18 | 14.18 | 13.97 | 12.11 | 11.51 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 13.36 | 19.60 | 17.99 | 18.56 | 14.78 | 8.12 | 9.45 | 14.37 |
| Interest Expense | 6.13 | 6.08 | 6.00 | 5.91 | 5.83 | 5.77 | 5.66 | 5.87 |
| Unusual Expense | 42.91 | 5.63 | 2.05 | 0.69 | -1.69 | -5.78 | 2.87 | 50.59 |
| Net Income Before Taxes | -26.81 | 14.15 | 1.77 | 19.11 | 17.11 | 18.21 | 7.94 | -38.61 |
| Income Taxes | 11.62 | 9.14 | -6.56 | 5.83 | 2.20 | 3.35 | 2.11 | -4.74 |
| Consolidated Net Income | -38.43 | 5.01 | 8.33 | 13.29 | 14.91 | 14.87 | 5.83 | -33.87 |
| Net Income From Continuing Operations | -38.43 | 5.01 | 8.33 | 13.29 | 14.91 | 14.87 | 5.83 | -33.87 |
| Net Income | -38.43 | 5.01 | 8.33 | 13.29 | 14.91 | 14.87 | 5.83 | -33.87 |
| EPS (Recurring) | -0.15 | 0.16 | 0.17 | 0.24 | 0.24 | 0.19 | 0.14 | 0.03 |
| EPS (Basic, Before Extraordinaries) | -0.68 | 0.09 | 0.15 | 0.24 | 0.27 | 0.26 | 0.10 | -0.60 |
| EPS (Diluted) | -0.68 | 0.09 | 0.15 | 0.23 | 0.26 | 0.26 | 0.10 | -0.60 |
| EBITDA | 37.19 | 44.14 | 42.53 | 43.15 | 49.09 | 43.19 | 41.74 | 36.90 |
| Non-Operating Income (Expense) | 8.87 | 6.26 | -8.17 | 7.16 | 6.47 | 10.09 | 7.03 | 3.48 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 7.39 | 6.33 | 6.57 | 6.31 | 7.09 | 6.62 | 5.75 | 5.02 |
| Price To Earnings Ratio | - | 150.20 | 136.30 | 6,375.88 | - | - | - | - |
| Price To Sales Ratio | 13.50 | 9.84 | 8.75 | 12.58 | 10.67 | 10.43 | 11.06 | 12.72 |
| Gross Margin | 48.44 | 49.25 | 50.70 | 47.21 | 47.99 | 45.35 | 48.63 | 45.20 |
| Operating Margin | 6.38 | 9.60 | 9.26 | 9.38 | 7.83 | 4.45 | 5.59 | 8.58 |
| Net Margin | -18.36 | 2.45 | 4.29 | 6.71 | 7.90 | 8.15 | 3.45 | -20.21 |
| Shares Outstanding | 56.69 | 56.43 | 56.40 | 56.33 | 56.28 | 56.25 | 56.18 | 56.09 |
| Market Capitalization | 11,121.45 | 7,696.27 | 6,636.93 | 9,223.81 | 7,519.95 | 6,988.05 | 7,144.35 | 8,064.48 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 767.63 | 757.36 | 751.32 | 623.76 | 603.81 | 717.29 | 537.41 | 193.82 | 173.76 |
| Short Term Receivables | 158.59 | 134.12 | 124.16 | 116.25 | 117.42 | 71.39 | 43.67 | 35.75 | 27.74 |
| Inventories | 170.46 | 142.96 | 202.32 | 238.28 | 184.49 | 95.03 | 54.83 | 42.26 | 39.00 |
| Other Current Assets | 40.71 | 31.61 | 33.54 | 19.84 | 25.95 | 18.68 | 5.92 | 3.85 | 2.21 |
| Total Current Assets | 1,137.38 | 1,066.04 | 1,111.35 | 998.12 | 931.68 | 902.38 | 641.83 | 275.68 | 242.72 |
| Net Property, Plant & Equipment | 306.15 | 333.12 | 322.95 | 315.70 | 226.52 | 92.05 | 74.16 | 32.18 | 22.42 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 1,500.56 | 1,428.89 | 1,394.08 | 1,216.13 | 1,197.64 | 905.40 | 680.97 | 462.17 | 472.09 |
| Deferred Tax Assets | 0.69 | 0.75 | 1.53 | 0.84 | 1.90 | 2.48 | 2.92 | 4.36 | - |
| Other Assets | 4.91 | 0.87 | 1.28 | 0.81 | 0.61 | 0.57 | 0.24 | 0.23 | 6.30 |
| Total Assets | 2,949.70 | 2,829.67 | 2,831.18 | 2,531.60 | 2,358.35 | 1,902.89 | 1,400.11 | 774.62 | 743.52 |
| Short Term Debt Incl. Current Port. of LT Debt | 21.56 | 15.10 | 75.08 | 291.57 | 263.56 | 248.99 | 3.56 | 103.49 | 0.00 |
| Accounts Payable | 30.01 | 32.13 | 19.56 | 27.55 | 36.20 | 16.88 | 11.43 | 10.49 | 7.28 |
| Income Tax Payable | 3.59 | 1.42 | 6.81 | 2.46 | 4.98 | 1.42 | 3.87 | 1.02 | 1.67 |
| Other Current Liabilities | 80.67 | 78.13 | 63.48 | 82.61 | 70.51 | 51.66 | 29.46 | 14.84 | 16.26 |
| Total Current Liabilities | 135.83 | 126.79 | 164.94 | 404.20 | 375.26 | 318.96 | 48.31 | 129.84 | 25.21 |
| Long Term Debt | 668.39 | 671.14 | 636.72 | 131.39 | 102.49 | 26.43 | 259.76 | 0.00 | 99.25 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 22.50 | 22.77 | 39.32 | 23.00 | 33.48 | 27.03 | 29.94 | 25.09 | 25.17 |
| Other Liabilities | 16.86 | 36.24 | 25.35 | 62.31 | 97.05 | 1.32 | 2.33 | 4.12 | 2.34 |
| Total Liabilities | 843.57 | 856.95 | 866.34 | 620.90 | 608.29 | 373.74 | 340.35 | 159.05 | 151.97 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 2,106.13 | 1,972.72 | 1,964.85 | 1,910.70 | 1,750.07 | 1,529.15 | 1,059.77 | 615.57 | 591.55 |
| Total Shareholders Equity | 2,106.13 | 1,972.72 | 1,964.85 | 1,910.70 | 1,750.07 | 1,529.15 | 1,059.77 | 615.57 | 591.55 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 2,106.13 | 1,972.72 | 1,964.85 | 1,910.70 | 1,750.07 | 1,529.15 | 1,059.77 | 615.57 | 591.55 |
| Total Liabilities & Stockholders Equity | 2,949.70 | 2,829.67 | 2,831.18 | 2,531.60 | 2,358.35 | 1,902.89 | 1,400.11 | 774.62 | 743.52 |
| Book Value Per Share | 37.39 | 35.17 | 35.23 | 34.39 | 31.63 | 27.92 | 20.35 | 14.02 | 13.57 |
| Tangible Book Value Per Share | 10.75 | 9.70 | 10.24 | 12.50 | 9.99 | 11.39 | 7.27 | 3.49 | 2.74 |
| Full-Time Employees | 2,000 | 1,778 | 1,783 | 2,025 | 1,852 | 1,128 | 761 | 548 | 476 |
| Price to Book Ratio | 4.72 | 4.00 | 5.04 | 5.12 | 8.37 | 6.86 | 4.55 | 3.76 | 2.74 |
| Return on Assets | 1.69 | -0.90 | 1.33 | 7.61 | 6.02 | 3.63 | 1.97 | 2.19 | 5.49 |
| Return on Equity | 2.40 | -1.30 | 1.84 | 10.16 | 7.82 | 4.63 | 2.56 | 2.75 | 7.46 |
| Return on Invested Capital | 1.76 | -0.97 | 1.37 | 9.11 | 6.93 | 3.85 | 1.62 | 2.70 | 4.10 |
| Quick Ratio | 7.12 | 7.28 | 5.51 | 1.88 | 1.99 | 2.53 | 12.15 | 1.80 | 8.08 |
| Current Ratio | 8.37 | 8.41 | 6.74 | 2.47 | 2.48 | 2.83 | 13.28 | 2.12 | 9.63 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -11.80 | 48.89 | -25.51 | 35.60 | 185.96 | 128.29 | 59.93 | 21.41 | 16.62 |
| Depreciation | 96.73 | 96.96 | 86.56 | 86.11 | 57.01 | 38.45 | 27.07 | 20.87 | 15.78 |
| Other Funds (Non Cash) | 102.80 | 25.82 | 70.22 | 11.13 | 0.30 | 47.89 | 28.24 | 26.70 | 14.44 |
| Funds from Operations | 189.19 | 168.30 | 114.47 | 134.01 | 241.92 | 221.14 | 111.25 | 68.35 | 46.90 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -59.33 | -50.88 | 60.92 | -20.09 | -69.84 | -102.13 | -48.62 | -1.14 | -14.13 |
| Cash from Operating Activities | 129.86 | 117.42 | 175.39 | 113.92 | 172.08 | 119.02 | 62.62 | 67.22 | 32.77 |
| Capital Expenditures | -24.61 | -25.73 | -32.91 | -38.99 | -133.35 | -71.28 | -26.34 | -23.15 | -14.04 |
| Net Assets From Acquisitions | -0.37 | -70.33 | -54.77 | -186.64 | 0.00 | -149.89 | -175.04 | -182.15 | 0.00 |
| Sale of Fixed Assets and Businesses | 3.83 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -129.68 | -200.26 | 0.00 | 102.32 | -100.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | -400.76 | -200.26 | 0.00 | 0.00 | -100.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 271.07 | 0.00 | 0.00 | 102.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | -2.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 1.29 | 0.03 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -150.83 | -298.47 | -86.38 | -123.28 | -233.24 | -221.17 | -201.38 | -205.31 | -14.04 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 16.88 | 3.18 | 4.29 | -13.31 | 3.71 | 3.88 | 305.93 | 321.88 | 3.42 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | -14.39 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 16.88 | 3.18 | 4.29 | 1.08 | 3.71 | 3.88 | 305.93 | 321.88 | 3.42 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 297.77 | 320.71 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | -69.94 | 282.84 | 0.00 | -0.02 | 0.00 | 163.48 | -0.01 |
| Change in Long Term Debt | 0.00 | 0.00 | -69.94 | 282.84 | 0.00 | -0.02 | 0.00 | 163.48 | -0.01 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 282.84 | 0.00 | 0.00 | 0.00 | 278.47 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | -69.94 | 0.00 | 0.00 | -0.02 | 0.00 | -114.99 | -0.01 |
| Net Financing Active Other Cash Flow | -13.83 | -18.38 | -17.26 | -20.57 | -17.04 | -2.90 | -0.01 | -0.49 | 0.00 |
| Other Financing Activities Uses | -13.83 | -18.38 | -17.26 | -20.57 | -17.04 | -2.90 | -0.01 | -0.49 | 0.00 |
| Cash from Financing Activities | 3.06 | -15.21 | -82.90 | 248.96 | -13.34 | 0.96 | 305.92 | 484.87 | 3.41 |
| Exchange Rate Effect | -1.82 | 4.93 | -0.08 | -11.74 | -5.87 | -12.29 | 12.73 | -3.19 | -2.08 |
| Net Change in Cash | -19.74 | -191.33 | 6.03 | 227.87 | -80.36 | -113.48 | 179.88 | 343.58 | 20.06 |
| Free Cash Flow | 105.26 | 91.69 | 145.50 | 74.93 | 38.74 | 47.74 | 36.28 | 44.06 | 19.99 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow | 103.29 | 101.08 | 55.34 | 135.28 | 251.12 | 317.67 | 284.65 | 103.30 | 119.98 |
| Deferred Taxes & Investment Tax Credit | - | -3.37 | -16.79 | 1.18 | -1.35 | 6.52 | -3.99 | -0.62 | 0.07 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 865.03 | 810.45 | 784.53 | 767.63 | 748.75 | 708.86 |
| Short Term Receivables | 151.24 | 157.71 | 151.55 | 158.59 | 148.97 | 156.95 |
| Inventories | 182.21 | 186.60 | 179.26 | 170.46 | 160.32 | 155.86 |
| Other Current Assets | 43.52 | 45.79 | 46.02 | 40.71 | 38.45 | 35.20 |
| Total Current Assets | 1,241.98 | 1,200.55 | 1,161.36 | 1,137.38 | 1,096.48 | 1,056.87 |
| Net Property, Plant & Equipment | 276.03 | 283.07 | 287.11 | 306.15 | 313.09 | 321.17 |
| Total Investments and Advances | 0.00 | 2.02 | 1.99 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 1,405.61 | 1,461.81 | 1,475.06 | 1,500.56 | 1,508.18 | 1,520.22 |
| Deferred Tax Assets | 0.72 | 0.70 | 1.36 | 0.69 | 0.86 | 0.80 |
| Other Assets | 2.06 | 2.03 | 3.89 | 4.91 | 5.11 | 2.57 |
| Total Assets | 2,926.41 | 2,950.18 | 2,930.77 | 2,949.70 | 2,923.71 | 2,901.63 |
| Short Term Debt Incl. Current Port. of LT Debt | 20.40 | 19.32 | 21.07 | 21.56 | 19.31 | 16.04 |
| Accounts Payable | 27.70 | 33.23 | 34.66 | 30.01 | 29.43 | 25.62 |
| Income Tax Payable | 0.76 | 0.41 | 0.90 | 3.59 | 2.85 | 1.41 |
| Other Current Liabilities | 76.83 | 79.69 | 69.58 | 80.67 | 79.54 | 79.94 |
| Total Current Liabilities | 125.69 | 132.66 | 126.21 | 135.83 | 131.14 | 123.01 |
| Long Term Debt | 671.84 | 671.62 | 666.55 | 668.39 | 669.55 | 670.02 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 19.91 | 16.78 | 15.02 | 22.50 | 20.14 | 23.33 |
| Other Liabilities | 17.23 | 17.09 | 17.53 | 16.86 | 19.80 | 23.53 |
| Total Liabilities | 834.67 | 838.15 | 825.31 | 843.57 | 840.62 | 839.89 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 2,091.74 | 2,112.03 | 2,105.46 | 2,106.13 | 2,083.09 | 2,061.74 |
| Total Shareholders Equity | 2,091.74 | 2,112.03 | 2,105.46 | 2,106.13 | 2,083.09 | 2,061.74 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 2,091.74 | 2,112.03 | 2,105.46 | 2,106.13 | 2,083.09 | 2,061.74 |
| Total Liabilities & Stockholders Equity | 2,926.41 | 2,950.18 | 2,930.77 | 2,949.70 | 2,923.71 | 2,901.63 |
| Book Value Per Share | 36.90 | 37.43 | 37.33 | 37.39 | 37.01 | 36.65 |
| Tangible Book Value Per Share | 12.10 | 11.52 | 11.18 | 10.75 | 10.21 | 9.63 |
| Full-Time Employees | - | - | - | 2,000 | - | - |
| Price to Book Ratio | 4.72 | 3.65 | 3.15 | 4.43 | 3.65 | 3.52 |
| Return on Assets | -0.40 | 1.42 | 1.78 | 1.69 | 0.06 | -0.48 |
| Return on Equity | -0.57 | 1.99 | 2.51 | 2.40 | 0.08 | -0.68 |
| Return on Invested Capital | -1.39 | 0.18 | 0.30 | 0.48 | 0.54 | 0.54 |
| Quick Ratio | 8.43 | 7.64 | 7.78 | 7.12 | 7.14 | 7.32 |
| Current Ratio | 9.88 | 9.05 | 9.20 | 8.37 | 8.36 | 8.59 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | -38.43 | 5.01 | 8.33 | 13.29 | 14.91 | 14.87 |
| Depreciation | 23.83 | 23.77 | 24.54 | 24.59 | 24.41 | 24.77 |
| Other Funds (Non Cash) | 53.98 | 14.03 | 25.02 | 9.77 | -0.01 | 2.48 |
| Funds from Operations | 43.20 | 45.74 | 50.19 | 50.06 | 36.10 | 40.74 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -0.10 | -12.97 | -21.90 | -24.35 | 12.00 | -12.14 |
| Cash from Operating Activities | 43.10 | 32.77 | 28.30 | 25.70 | 48.10 | 28.61 |
| Capital Expenditures | -5.28 | -6.07 | -4.95 | -8.31 | -5.39 | -7.61 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | -0.37 | 0.00 | -0.23 |
| Sale of Fixed Assets and Businesses | 0.00 | 3.64 | 0.00 | 0.20 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 69.27 | -0.07 | 1.38 | -200.26 | 0.00 | 0.00 |
| Purchase of Investments | -69.80 | -66.07 | -64.62 | -200.26 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 139.07 | 66.00 | 66.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.42 | -0.42 | 0.00 | -2.40 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 63.99 | -2.09 | -3.99 | -208.74 | -7.78 | -7.84 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 15.76 | 0.09 | 0.00 | 1.03 | 0.68 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 15.76 | 0.09 | 0.00 | 1.03 | 0.68 | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -1.15 | -6.29 | -5.54 | -0.84 | -0.92 | -10.13 |
| Other Financing Activities Uses | -1.15 | -6.29 | -5.54 | -0.84 | -0.92 | -10.13 |
| Cash from Financing Activities | 14.60 | -6.20 | -5.54 | 0.20 | -0.24 | -10.13 |
| Exchange Rate Effect | -1.49 | -0.31 | -0.14 | 0.12 | -0.18 | 0.99 |
| Net Change in Cash | 120.20 | 24.17 | 18.62 | -182.73 | 39.89 | 11.63 |
| Free Cash Flow | 37.82 | 26.70 | 23.35 | 17.39 | 42.71 | 21.00 |
| Price to Free Cash Flow | 103.29 | 70.15 | 63.91 | 101.26 | 70.97 | 66.34 |
Revenue breakdown
| Product | 2024: 634.18M 2025: 737.96M |
|---|---|
| Royalty | 2024: 261.00K 2025: 296.00K |
| United States | 2024: 634.44M 2025: 738.26M |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 11.68% | 7.1M | 60.4M | 1.18M |
| 2026-10-15 | 11.92% | 7.1M | 60.0M | 1.21M |
| 2026-09-30 | 14.22% | 7.6M | 53.3M | 1.09M |
| 2026-09-15 | 12.59% | 6.7M | 53.3M | 1.11M |
| 2026-08-31 | 12.41% | 6.6M | 53.3M | 1.10M |
| 2026-08-14 | 11.42% | 6.1M | 53.3M | 1.16M |
| 2026-07-31 | 11.49% | 6.1M | 53.4M | 1.23M |
| 2026-07-15 | 10.90% | 5.8M | 53.3M | 1.14M |
| 2026-06-30 | 11.34% | 6.0M | 53.3M | 1.15M |
| 2026-06-15 | 10.74% | 5.7M | 53.3M | 1.08M |
| 2026-05-29 | 11.17% | 6.0M | 53.4M | 1.08M |
| 2026-05-15 | 10.67% | 5.7M | 53.4M | 1.04M |
| 2026-04-30 | 10.31% | 5.5M | 53.4M | 931.69K |
| 2026-04-15 | 10.27% | 5.5M | 53.4M | 843.78K |
| 2026-03-31 | 10.43% | 5.6M | 53.3M | 828.92K |
| 2026-03-13 | 8.15% | 4.3M | 53.3M | 755.30K |
| 2026-02-27 | 7.52% | 4.0M | 53.3M | 706.71K |
| 2026-02-13 | 7.61% | 4.0M | 53.2M | 686.35K |
| 2026-01-30 | 7.62% | 4.1M | 53.2M | 689.60K |
| 2026-01-15 | 7.37% | 3.9M | 53.2M | 801.64K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 55.00 | 116.1 | 119.8 | 114.7 | 5.095 | 2.00 | 0.00 | 0.975 | -0.407 | 0.016 |
| call | 60.00 | 111.1 | 114.8 | 124.5 | 4.737 | 1.00 | 0.00 | 0.973 | -0.405 | 0.017 |
| call | 65.00 | 106.1 | 109.9 | 102.1 | 4.410 | 3.00 | 0.00 | 0.971 | -0.403 | 0.018 |
| call | 70.00 | 101.1 | 104.9 | 94.14 | 4.109 | 6.00 | 0.00 | 0.969 | -0.401 | 0.019 |
| call | 75.00 | 96.30 | 99.90 | 94.80 | 3.831 | 4.00 | 0.00 | 0.966 | -0.398 | 0.020 |
| call | 80.00 | 91.20 | 94.90 | 0.00 | 3.571 | 0.00 | 0.00 | 0.964 | -0.394 | 0.021 |
| call | 85.00 | 85.90 | 89.90 | 100.3 | 3.328 | 3.00 | 0.00 | 0.961 | -0.390 | 0.023 |
| call | 90.00 | 81.00 | 84.90 | 79.90 | 3.099 | 1.00 | 0.00 | 0.958 | -0.386 | 0.024 |
| call | 95.00 | 76.50 | 79.90 | 0.00 | 2.882 | 0.00 | 0.00 | 0.955 | -0.381 | 0.025 |
| call | 100 | 71.10 | 74.90 | 67.50 | 2.676 | 4.00 | 0.00 | 0.951 | -0.376 | 0.027 |
| call | 105 | 66.50 | 69.90 | 49.73 | 2.507 | 4.00 | 0.00 | 0.948 | -0.370 | 0.029 |
| call | 110 | 61.30 | 64.90 | 40.00 | 2.318 | 0.00 | 0.00 | 0.943 | -0.363 | 0.031 |
| call | 115 | 56.60 | 59.90 | 61.75 | 2.135 | 130 | 0.00 | 0.939 | -0.356 | 0.033 |
| call | 120 | 51.30 | 54.90 | 47.90 | 1.960 | 4.00 | 0.00 | 0.933 | -0.349 | 0.035 |
| call | 125 | 46.70 | 50.00 | 49.00 | 1.790 | 7.00 | 0.00 | 0.927 | -0.340 | 0.037 |
| call | 130 | 41.60 | 45.00 | 49.28 | 1.624 | 5.00 | 0.00 | 0.901 | -0.429 | 0.047 |
| call | 135 | 36.50 | 39.30 | 39.20 | 1.482 | 5.00 | 0.00 | 0.888 | -0.427 | 0.051 |
| call | 140 | 31.50 | 34.40 | 37.60 | 1.340 | 13.00 | 0.00 | 0.874 | -0.422 | 0.056 |
| call | 145 | 26.90 | 30.00 | 29.60 | 1.116 | 32.00 | 0.00 | 0.853 | -0.424 | 0.062 |
| call | 150 | 22.10 | 25.50 | 23.20 | 1.083 | 20.00 | 0.00 | 0.827 | -0.424 | 0.069 |
| call | 155 | 17.70 | 21.00 | 31.00 | 0.986 | 77.00 | 0.00 | 0.795 | -0.415 | 0.076 |
| call | 160 | 13.50 | 16.50 | 15.30 | 0.897 | 10.00 | 0.00 | 0.739 | -0.440 | 0.087 |
| call | 165 | 9.70 | 12.90 | 13.17 | 0.817 | 146 | 135 | 0.671 | -0.440 | 0.097 |
| call | 170 | 5.80 | 9.50 | 8.03 | 0.756 | 26.00 | 0.00 | 0.580 | -0.436 | 0.105 |
| call | 175 | 3.30 | 6.50 | 5.70 | 0.701 | 8.00 | 3.00 | 0.474 | -0.422 | 0.107 |
| call | 180 | 2.50 | 5.00 | 3.65 | 0.741 | 34.00 | 3.00 | 0.379 | -0.423 | 0.102 |
| call | 185 | 0.00 | 3.70 | 5.60 | 0.761 | 14.00 | 0.00 | 0.298 | -0.399 | 0.093 |
| call | 190 | 0.35 | 3.10 | 1.05 | 0.825 | 170 | 0.00 | 0.250 | -0.403 | 0.085 |
| call | 195 | 0.00 | 2.50 | 0.75 | 0.867 | 49.00 | 0.00 | 0.204 | -0.377 | 0.076 |
| call | 200 | 0.00 | 2.35 | 3.10 | 0.953 | 58.00 | 0.00 | 0.181 | -0.384 | 0.071 |
| call | 210 | 0.00 | 2.30 | 0.71 | 1.030 | 60.00 | 0.00 | 0.128 | -0.330 | 0.056 |
| call | 220 | 0.00 | 2.15 | 1.10 | 1.196 | 53.00 | 0.00 | 0.114 | -0.353 | 0.052 |
| call | 230 | 0.00 | 2.15 | 0.35 | 1.348 | 16.00 | 1.00 | 0.104 | -0.372 | 0.048 |
| call | 240 | 0.00 | 2.15 | 1.15 | 1.489 | 6.00 | 0.00 | 0.096 | -0.388 | 0.046 |
| call | 250 | 0.00 | 2.15 | 4.30 | 1.620 | 205 | 0.00 | 0.090 | -0.402 | 0.044 |
| call | 260 | 0.00 | 0.10 | 2.30 | 1.559 | 2.00 | 0.00 | 0.075 | -0.321 | 0.040 |
| call | 270 | 0.00 | 2.15 | 0.00 | 1.169 | 0.00 | 0.00 | 0.010 | -0.047 | 0.007 |
| call | 280 | 0.00 | 2.15 | 0.50 | 1.251 | 4.00 | 0.00 | 0.009 | -0.048 | 0.007 |
| put | 55.00 | 0.00 | 2.15 | 1.20 | 4.537 | 2.00 | 0.00 | -0.024 | -0.391 | 0.016 |
| put | 60.00 | 0.00 | 2.15 | 1.70 | 4.221 | 2.00 | 0.00 | -0.026 | -0.389 | 0.017 |
| put | 65.00 | 0.00 | 2.15 | 1.40 | 3.955 | 14.00 | 0.00 | -0.029 | -0.396 | 0.018 |
| put | 70.00 | 0.00 | 2.15 | 1.90 | 3.679 | 7.00 | 0.00 | -0.031 | -0.388 | 0.019 |
| put | 75.00 | 0.00 | 2.15 | 1.20 | 3.424 | 9.00 | 0.00 | -0.033 | -0.386 | 0.020 |
| put | 80.00 | 0.00 | 2.15 | 1.05 | 3.197 | 4.00 | 0.00 | -0.036 | -0.385 | 0.021 |
| put | 85.00 | 0.00 | 2.15 | 1.35 | 2.977 | 4.00 | 0.00 | -0.039 | -0.381 | 0.023 |
| put | 90.00 | 0.00 | 2.15 | 2.10 | 2.770 | 2.00 | 0.00 | -0.042 | -0.376 | 0.024 |
| put | 95.00 | 0.00 | 2.15 | 2.75 | 2.573 | 3.00 | 0.00 | -0.045 | -0.370 | 0.026 |
| put | 100 | 0.00 | 2.15 | 5.90 | 2.386 | 70.00 | 0.00 | -0.049 | -0.364 | 0.027 |
| put | 105 | 0.00 | 2.15 | 0.30 | 2.208 | 372 | 0.00 | -0.052 | -0.358 | 0.029 |
| put | 110 | 0.00 | 2.15 | 0.50 | 2.036 | 503 | 0.00 | -0.057 | -0.351 | 0.031 |
| put | 115 | 0.00 | 2.15 | 3.30 | 1.872 | 6.00 | 0.00 | -0.061 | -0.344 | 0.033 |
| put | 120 | 0.00 | 2.15 | 0.04 | 1.714 | 705 | 0.00 | -0.067 | -0.335 | 0.035 |
| put | 125 | 0.00 | 1.50 | 1.35 | 1.559 | 291 | 0.00 | -0.073 | -0.326 | 0.037 |
| put | 130 | 0.00 | 2.20 | 2.00 | 1.571 | 63.00 | 0.00 | -0.099 | -0.415 | 0.047 |
| put | 135 | 0.00 | 2.30 | 2.10 | 1.434 | 142 | 0.00 | -0.112 | -0.412 | 0.051 |
| put | 140 | 0.00 | 2.40 | 3.00 | 1.297 | 100 | 0.00 | -0.126 | -0.406 | 0.056 |
| put | 145 | 0.00 | 2.60 | 1.65 | 1.176 | 15.00 | 0.00 | -0.147 | -0.408 | 0.062 |
| put | 150 | 0.00 | 2.85 | 0.98 | 1.057 | 32.00 | 0.00 | -0.173 | -0.407 | 0.069 |
| put | 155 | 0.00 | 3.10 | 0.90 | 0.931 | 98.00 | 1.00 | -0.205 | -0.398 | 0.076 |
| put | 160 | 0.20 | 3.90 | 1.73 | 0.860 | 11.00 | 0.00 | -0.261 | -0.422 | 0.087 |
| put | 165 | 0.90 | 4.70 | 6.00 | 0.764 | 160 | 0.00 | -0.329 | -0.422 | 0.097 |
| put | 170 | 2.25 | 6.00 | 6.30 | 0.688 | 297 | 0.00 | -0.420 | -0.417 | 0.105 |
| put | 175 | 5.30 | 8.30 | 7.45 | 0.663 | 42.00 | 0.00 | -0.526 | -0.403 | 0.107 |
| put | 180 | 8.20 | 11.50 | 14.30 | 0.672 | 109 | 0.00 | -0.621 | -0.403 | 0.102 |
| put | 185 | 11.60 | 15.00 | 15.40 | 0.663 | 5.00 | 0.00 | -0.702 | -0.378 | 0.093 |
| put | 190 | 15.90 | 19.20 | 20.30 | 0.690 | 64.00 | 0.00 | -0.750 | -0.382 | 0.085 |
| put | 195 | 20.50 | 23.80 | 21.14 | 0.743 | 0.00 | 0.00 | -0.796 | -0.355 | 0.076 |
| put | 200 | 25.30 | 28.70 | 33.90 | 0.826 | 18.00 | 0.00 | -0.819 | -0.362 | 0.071 |
| put | 210 | 35.30 | 38.80 | 33.55 | 0.970 | 6.00 | 0.00 | -0.872 | -0.306 | 0.056 |
| put | 220 | 45.30 | 48.50 | 45.50 | 1.132 | 0.00 | 0.00 | -0.886 | -0.328 | 0.052 |
| put | 230 | 55.30 | 58.50 | 54.90 | 1.282 | 0.00 | 0.00 | -0.896 | -0.346 | 0.048 |
| put | 240 | 65.30 | 68.50 | 73.60 | 1.421 | 0.00 | 0.00 | -0.904 | -0.361 | 0.046 |
| put | 250 | 75.30 | 78.50 | 0.00 | 1.552 | 0.00 | 0.00 | -0.910 | -0.375 | 0.044 |
| put | 260 | 85.30 | 88.50 | 73.90 | 1.675 | 0.00 | 0.00 | -0.990 | -0.018 | 0.007 |
| put | 270 | 95.30 | 98.50 | 0.00 | 1.792 | 0.00 | 0.00 | -0.990 | -0.017 | 0.007 |
| put | 280 | 105.3 | 108.5 | 0.00 | 1.903 | 0.00 | 0.00 | -0.991 | -0.017 | 0.007 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-06 | 8-K | Current report | 2026-11-06 | SEC |
| 2026-10-30 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-10-30 | 8-K | Current report | 2026-10-29 | SEC |
| 2026-10-27 | 8-K | Current report | 2026-10-27 | SEC |
| 2026-10-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-06 | SEC |
| 2026-10-07 | SCHEDULE 13G/A | SEC | ||
| 2026-10-06 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-05 | SEC |
| 2026-10-06 | 8-K | Current report | 2026-10-06 | SEC |
| 2026-10-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-02 | SEC |
| 2026-09-30 | 425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions. | SEC | |
| 2026-09-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-25 | SEC |
| 2026-09-25 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-24 | SEC |
| 2026-09-24 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-22 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-21 | SEC |
| 2026-09-21 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-15 | 8-K | Current report | 2026-09-10 | SEC |
| 2026-09-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-03 | SEC |
| 2026-09-08 | 425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions. | SEC | |
| 2026-09-08 | 8-K | Current report | 2026-09-03 | SEC |
| 2026-09-04 | EFFECT | Effectiveness filing by commission order | SEC | |
| 2026-09-04 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-04 | 424B3 | SEC | ||
| 2026-09-04 | S-4/A | SEC | ||
| 2026-09-02 | 4 | Statement of changes in beneficial ownership of securities | 2026-03-05 | SEC |
| 2026-08-25 | S-4 | Registration statement for securities to be issued in business combination transactions | SEC | |
| 2026-08-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-20 | SEC |
| 2026-08-20 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-14 | SCHEDULE 13G/A | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 1.04M | 1 |
| 2026-09 | 0 | 0 | 3.94M | 3 |
| 2026-08 | 0 | 0 | 976.68K | 1 |
| 2026-07 | 0 | 0 | 79.50K | 1 |
| 2026-06 | 0 | 0 | 106.29K | 1 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 536.48K | 1 |
| 2026-03 | 0 | 0 | 0 | 0 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 44.28K | 1 |
| 2025-11 | 0 | 0 | 8.54M | 4 |
Institutional holders
| Manager | % owned |
|---|---|
| FMR LLC | 13.03% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 11.52% |
| BlackRock, Inc. | 9.55% |
| STATE OF WISCONSIN INVESTMENT BOARD | 7.15% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 4.95% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.27% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.10% |
| MAVERICK CAPITAL LTD | 3.52% |
| STATE STREET CORP | 3.19% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.11% |
Funds
| Fund | % owned |
|---|---|
| Franklin Convertible Securities Fund | 63.79% |
| iShares Convertible Bond ETF | 21.34% |
| State Street(R) SPDR(R) Bloomberg Convertible Securities ETF | 15.53% |
| Putnam Convertible Securities Fund | 8.48% |
| CALAMOS CONVERTIBLE & HIGH INCOME FUND | 8.42% |
| CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND | 7.53% |
| Calamos Convertible Fund | 7.09% |
| Fidelity Convertible Securities Fund | 6.81% |
| Calamos Dynamic Convertible & Income Fund | 6.64% |
| Miller Market Neutral Income Fund | 5.32% |
OakChart. RGEN. Cached 15 minutes.